Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
1.19M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
264K
-
Shares change
-
+125K
-
Total reported value, excl. options
-
$153K
-
Value change
-
+$67.2K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$0.58
Significant Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q1 2024
15 filings reported holding NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 264K shares
of 1.19M outstanding shares and own 22.25% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (54.2K shares), TWO SIGMA SECURITIES, LLC (47.9K shares), VANGUARD GROUP INC (39.8K shares), JANE STREET GROUP, LLC (36.1K shares), Virtu Financial LLC (34.6K shares), NewEdge Advisors, LLC (30.9K shares), XTX Topco Ltd (10.8K shares), Tower Research Capital LLC (TRC) (8.66K shares), MORGAN STANLEY (332 shares), and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (329 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.